Subcutaneous Micro-Pellet Implants for Sustained Naltrexone Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatment methods for addiction and chronic conditions face challenges such as poor compliance with medication regimens, high costs, severe side effects, and the need for comprehensive recovery programs that address psychological and emotional support, particularly in remote or underserved areas.
Innovation Solution
The Delaney Method employs subcutaneous micro-pellet implants with medication like Naltrexone combined with stearic acid for extended release, paired with Holographical Reality for remote counseling and identification using RFID microchips, facilitating access to a network of medical professionals and psychologists, and providing a comprehensive treatment program including medical treatments and counseling.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If extended-release injectable suspension (Vivitrol) is used, then treatment duration is extended and compliance is improved, but severe injection site reactions and high cost occur
Solution Approach 1:
The patent segments the medication delivery system into multiple small implants (e.g., 2-5 implants per injection site) rather than using a single large injection. Each implant is approximately 0.5-2 cm in length and contains a controlled amount of medication (e.g., 10-50 mg naltrexone). This segmentation distributes the medication release across multiple small sites, reducing localized tissue damage and severe reactions while maintaining extended treatment duration.
Solution Approach 2:
The patent introduces a biocompatible polymer matrix or biodegradable carrier as an intermediary between the medication and body tissues. This intermediary material controls the release rate of the medication, provides a physical barrier that reduces direct tissue irritation, and allows for sustained delivery over months while minimizing injection site reactions.
2Duration of action of moving object
If Vivitrol injections are used, then treatment compliance is improved, but cost increases significantly
Solution Approach 1:
The patent changes the dosage parameters from high-dose monthly injections (380 mg naltrexone) to lower-dose implants distributed over multiple sites (e.g., 10-50 mg per implant). This parameter change allows for equivalent or superior therapeutic effect while reducing the total cost of treatment, as the implants can be manufactured more economically and eliminate the need for expensive proprietary injection formulations.
3Duration of action of moving object
If subcutaneous pellet implants are used, then treatment duration is extended, but visible bulge and stitches are created
Solution Approach 1:
The patent divides the medication delivery function into multiple small implants (2-5 per site) rather than one large pellet. Each implant is small (0.5-2 cm) and can be distributed across a broader subcutaneous area, preventing the formation of a single visible bulge. The segmented approach allows for better tissue integration and more natural appearance.
Solution Approach 2:
The patent selects specific injection sites and orientations to optimize cosmetic outcomes. Implants are placed in areas with sufficient subcutaneous tissue depth to mask visibility, and injection angles are chosen to minimize surface protrusion. The local quality of the implant placement is optimized for each anatomical site to prevent visible deformities while maintaining effective medication delivery.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances medication compliance, reduces costs and side effects, and offers comprehensive psychological and emotional support, enabling effective long-term recovery by providing accessible and trustworthy treatment services to individuals with addiction and chronic conditions, regardless of geographic location.
Implementation Method 1
subcutaneous micro-pellet implants with medication like Naltrexone combined with stearic acid for extended release
Data Source
AI summary
A comprehensive addiction treatment method with a medication delivery system of subcutaneous implant of micro-pellets in patients, which may include a method of identification at an advanced video communication system through facial recognition, voice recognition and/or a recognition of an RFID microchip implanted in a patient. The identification will be transmitted over the Internet to a database at a secure server to initiate a computer program to stream video content, computer generated communication and/or a live video to be transmitted to an audio-visual system that may be capable of displaying a life-size video image of a live caregiver or a computer generated avatar of a caregiver within a three dimensional setting for real time two-way communication with apparent eye contact.